Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-000991
Filing Date
2017-01-06
Accepted
2017-01-06 16:39:50
Documents
1
Period of Report
2017-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7307
  Complete submission text file 0001140361-17-000991.txt   9152
Mailing Address 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020
Business Address 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020 212-956-2221
PAULSON & CO. INC. (Reporting) CIK: 0001035674 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 17514697

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations